Breast Ultrasound Market Report 2025

The breast ultrasound market size has grown rapidly in recent years. It will grow from $2.74 billion in 2024 to $3.09 billion in 2025 at a compound annual growth rate (CAGR) of 12.9%. The growth during the historical period can be attributed to increased breast cancer awareness campaigns, the expansion of screening programs in developed nations, heightened familiarity with conventional ultrasound imaging, a growing preference for non-invasive diagnostic methods, and the rising use of breast ultrasound as an auxiliary screening tool.

The breast ultrasound market size is expected to see rapid growth in the next few years. It will grow to $4.96 billion in 2029 at a compound annual growth rate (CAGR) of 12.6%. The anticipated growth during the forecast period can be attributed to the adoption of AI-enabled breast ultrasound systems, the increasing incidence of breast cancer among younger individuals, rising demand for point-of-care ultrasound devices, expansion of automated breast ultrasound (ABUS), and growing investments in digital health infrastructure and tele-imaging. Key trends expected in this period include advancements in AI-powered ultrasound systems, the development of portable and handheld breast ultrasound devices, progress in 3D and 4D imaging technologies, the use of elastography for assessing tissue stiffness, and integration with cloud-based data analytics platforms.

The rising incidence of breast cancer is anticipated to drive the growth of the breast ultrasound market. Breast cancer originates in breast tissue and can spread to nearby areas or other parts of the body. The increase in breast cancer cases is linked to greater exposure to lifestyle-related risk factors, such as obesity, which affects hormone levels and encourages cancer development. Breast ultrasound plays a crucial role in addressing this rise by offering a reliable, non-invasive method for early detection and precise differentiation of breast abnormalities, particularly in dense breast tissue. For example, in October 2024, the American Cancer Society, a US-based cancer organization, reported that in 2022, there were an estimated 287,850 new cases of invasive breast cancer and 51,400 cases of ductal carcinoma in situ (DCIS) diagnosed among women in the United States. These numbers are expected to increase to approximately 310,720 invasive cases and 56,500 DCIS cases by 2024. This growing incidence is therefore fueling demand in the breast ultrasound market.

Leading companies in the breast ultrasound market are concentrating on developing advanced AI-powered breast ultrasound systems (BUS) to enhance diagnostic speed and early detection, especially for women with dense breast tissue. AI-integrated automated breast ultrasound systems (ABUS) incorporate artificial intelligence to support automated image capture, real-time quality assessment, and lesion detection, thereby reducing scan variability and reliance on operator skill. For instance, in March 2025, GE HealthCare, a US-based healthcare IT provider, launched the Invenia ABUS Premium, a patient-friendly 3D automated breast ultrasound system. This system received premarket approval from the U.S. FDA to improve detection sensitivity when used alongside mammography, addressing challenges related to dense breast tissue masking cancers in conventional screenings. Features include advanced AI tools such as Verisound AI for scan quality evaluation, automatic nipple detection, and a Fast Scan function that speeds scanning by up to 40%. Its non-invasive design also enhances patient comfort, lowers unnecessary biopsies, and eliminates radiation exposure.

In June 2025, RadNet Inc., a US-based provider of diagnostic imaging and digital health services, acquired See-Mode Technologies for an undisclosed sum. This acquisition enables RadNet to integrate See-Mode’s technology into its DeepHealth population health solutions, strengthening its position in AI-driven ultrasound innovation and addressing high demand and capacity challenges in ultrasound imaging. See-Mode Technologies is a Singapore-based company specializing in AI for breast ultrasound imaging.

Major players in the breast ultrasound market are Samsung Electronics Co. Ltd., Hitachi Ltd., Siemens Healthineers, Koninklijke Philips N.V., GE Healthcare, Hologic Inc., Mindray Medical International Limited, Canon Medical Systems Corporation, Carestream Health Inc., Blessing Health System, Fujifilm Sonosite Inc., Esaote S.p.A., Sonoscape Medical Corp., Shantou Institute of Ultrasonic Instruments, Terason, Delphinus Medical Technologies Inc., SonoCine Inc., Clarius Mobile Health Corp., QT Imaging Inc., QView Medical Inc.

North America was the largest region in the breast ultrasound market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in breast ultrasound report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the breast ultrasound market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The breast ultrasound market consists of revenues earned by entities by providing services such as detection of breast abnormalities, evaluation of dense breast tissue, guidance for biopsies, and assessment of symptoms. The market value includes the value of related goods sold by the service provider or included within the service offering. The breast ultrasound market includes sales of transducers, display screens, data storage systems, gel warmers, and ultrasound consoles. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers’ margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

The breast ultrasound market research report is one of a series of new reports that provides breast ultrasound market statistics, including the breast ultrasound industry global market size, regional shares, competitors with the breast ultrasound market share, detailed breast ultrasound market segments, market trends, opportunities, and any further data you may need to thrive in the breast ultrasound industry. This breast ultrasound market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Breast ultrasound is a non-invasive imaging method that employs high-frequency sound waves to generate real-time images of the breast’s internal structures. It is frequently used to assess abnormalities detected during a physical exam or mammogram, helping to differentiate between solid lumps and fluid-filled cysts.

The main types of breast ultrasound include conventional breast ultrasound (CBUS) and automated breast ultrasound (ABUS). Conventional breast ultrasound (CBUS) is an affordable, operator-dependent technique that uses a handheld transducer to identify lumps or cysts, particularly in women with dense breast tissue. It incorporates various technologies such as two-dimensional (2D), three-dimensional (3D), four-dimensional (4D) ultrasound, and Doppler ultrasound, and is utilized by a range of end users including hospitals and diagnostic imaging centers.

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.